Experienced in Familial Hypertension

Dr. Lowell Satler

Cardiology
110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, 
Washington, DC 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Familial Hypertension
110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lowell Satler is a Cardiologist in Washington, Washington, D.c.. Dr. Satler is rated as an Experienced provider by MediFind in the treatment of Familial Hypertension. His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Heart Attack, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 363 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in DC
Hospital Affiliations
Frederick Health Hospital
Medstar Washington Hospital Center
Luminis Health Anne Arundel Medical Center, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, Washington, DC 20010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS
OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
Enrollment Status: Active_not_recruiting
Publish Date: March 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Unknown
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study
Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Device
Study Phase: Not Applicable
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Enrollment Status: Unknown
Publish Date: January 04, 2022
Intervention Type: Other, Device
Study Phase: Not Applicable
Carotid With Bivalirudin Angioplasty
Carotid With Bivalirudin Angioplasty
Enrollment Status: Completed
Publish Date: October 28, 2020
Intervention Type: Device
Study Phase: Phase 2
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Enrollment Status: Unknown
Publish Date: January 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 12 Less Clinical Trials

363 Total Publications

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Journal: Lancet (London, England)
Published: September 30, 2025
Similar Doctors
Distinguished in Familial Hypertension
Dr. Sridhar Chatrathi
Cardiology
Distinguished in Familial Hypertension
Dr. Sridhar Chatrathi
Cardiology

Office

7500 Hanover Pkwy Ste 104, 
Greenbelt,, MD 
 (8.9 miles away)
301-220-2220
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sridhar Chatrathi is a Cardiologist in Greenbelt,, Maryland. Dr. Chatrathi is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertension. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Combined Hyperlipidemia.

Distinguished in Familial Hypertension
Dr. Nader Dakak
Cardiology
Distinguished in Familial Hypertension
Dr. Nader Dakak
Cardiology

Nader A Dakak MD

12150 Annapolis Rd Ste 105, 
Glenn Dale, MD 
 (12.1 miles away)
301-805-1250
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nader Dakak is a Cardiologist in Glenn Dale, Maryland. Dr. Dakak is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertension. His top areas of expertise are Angina, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Distinguished in Familial Hypertension
Dr. Khalid Ashai
Cardiology
Distinguished in Familial Hypertension
Dr. Khalid Ashai
Cardiology

Jaswinder S Sidhu MD Rishpal Singh MD & Steven Pollak MD PA

7525 Greenway Center Dr Ste 313, 
Greenbelt,, MD 
 (8.9 miles away)
301-345-4100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Khalid Ashai is a Cardiologist in Greenbelt,, Maryland. Dr. Ashai is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertension. His top areas of expertise are Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Satler's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 10 Distinguished Conditions
View All 20 Advanced Conditions
View All 60 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile